NCT01707537View on ClinicalTrials.gov

To Determine the Safety and Immunogenicity of an Oral(Whole Cell) Euvichol Cholera Vaccine in Healthy Adult Men

PHASE1CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

September 30, 2012

Primary Completion Date

February 28, 2013

Study Completion Date

February 28, 2013

Conditions
Prevention Harmful Effects
Interventions
BIOLOGICAL

Euvichol

1.5mL/vial, 1vial at 2-week intervals twice

Trial Locations (1)

301-721

Chungnam National University Hospital, Daejeon

Sponsors
All Listed Sponsors
collaborator

Instituto Universitario IVI

OTHER

lead

EuBiologics Co.,Ltd

INDUSTRY

NCT01707537 - To Determine the Safety and Immunogenicity of an Oral(Whole Cell) Euvichol Cholera Vaccine in Healthy Adult Men | Biotech Hunter | Biotech Hunter